Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
siRNA Microneedle Patches for Ear Keloid Post-Surgical Scars
NCT07596628Phase 2Not yet recruiting
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Modality
- Nanoparticles, Conjugated siRNA, Chemically Modified siRNA
- Countries
- 1
01
Overview
Phase 2, randomised trial of Prosemble siRNA nanoparticle in keloid (2 arms). Primary endpoints: Vancouver Scar Scale at Day 360 and Scar Cosmesis Assessment and Rating at Day 360. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
Prosemble siRNA nanoparticle
03
Conditions
keloid
Beyond the preview
Go deeper on NCT07596628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07596628.